Download presentation
Presentation is loading. Please wait.
Published bySusanna Andrews Modified over 8 years ago
1
Department of Pathology Benchmarking Marty Lawlor Friday, November 8, 2013
2
Financial Metrics Questions vs. Answers Reviewing financial data rarely gives us the answers we are looking for. It will direct us to the questions we need to ask about changes in our operations.
3
HOSPITAL METRICS
4
Hospital Consolidated FY13 June YTD Financials
5
Hospital Financial Performance FY13 December YTD by Entity
8
Hospital Pathology Consolidated Statement
9
Hospital Pathology Consolidated Statement Individual Lab
10
Managing a Practice
11
Sources of Departmental Revenue Clinical Revenue Margin – Currently 36% Extramural Funding – Direct & Indirect Costs Educational Transfers Part A Transfers Clinical Ph.D. Transfer Professional Component Billing Additional Contractual Agreements
12
Part A Role as a lab director Services provided to the facility or for the benefit of patients in general (autopsies) Part B Services provided to individual patients Surgical pathology Transfusion medicine Interpretive services Faculty Provide Both Part A and Part B Services
13
Clarified Part A and Part B services and payments Eliminated professional component billing on routine laboratory tests for Medicare inpatients (other payors have adopted this policy) Defined reasonable compensation equivalent (RCE) Part A Transfer is Payment for Professional Services Tax Equity and Fiscal Responsibility Act of 1982 (TEFRA)
14
Autopsies Medical Administration Supervisory and Consulting Activities Medical Education Part A Services
15
Assure accuracy of test results Interact with medical staff Establish parameters for performance of tests Recommend additional diagnostic/therapeutic tests Advise lab personnel regarding aberrant results Clinical Laboratory Improvements of 1988 Codified the Role of Lab Director
16
Select, evaluate and validate test methodologies Direct performance and evaluation of quality control and quality assurance procedures Evaluate clinical data; establish process for review of tests prior to issuance of patient reports Assure compliance with accrediting agencies Clinical Laboratory Improvements of 1988 Codified the Role of Lab Director
17
RVU Report
18
Collections
20
PART A REPORTING
21
Clinical Incentive Payment Calculations The Pathology Incentive program is divided into four major categories: Extramural Consults, Outreach Part B Billings, Outreach Part A Payment and Department margin. Incentives are provided twice a year (July – December; January – June). Limits to total compensation are imposed by the Medical School. The current salary limit is 25% or $60,000 per year, which ever is higher, of base, academic, clinical supplement A and administrative differential (basically total compensation received less the incentive payments). Extramural Consults Outreach Part B Billings Outreach Part A Payment Department Margin
23
RESEARCH
24
FINANCIAL SUMMARY FOR FACULTY X
25
FINANCIAL SUMMARY FOR FACULTY Y
26
Research Incentive
27
NATIONAL BENCHMARKING ISSUES Phlebotomy – Is it housed in Pathology or Nursing? Pathology Informatics – Departmental or centralized? Send-outs – Are these shown as supplies? Complexity of Test Menu
28
Case Studies Why are the total supplies and supply metrics for Molecular Diagnostics up? Why are FTE’s up across the board in FY14? Why are FTE’s up in Molecular Diagnostics? Why is there an increase in FTE’s in the HLA Lab?
29
Questions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.